Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 27 Carcinoma, Non-Small-Cell Lung 27 Brain Neoplasms 23 Lung Neoplasms 17 Neoplasm Metastasis 15 Breast Neoplasms 12 Melanoma 9 Carcinoma, Renal Cell 8 Pancreatic Neoplasms 7 Colorectal Neoplasms 6 Carcinoma, Hepatocellular 5 Urinary Bladder Neoplasms 3 Neoplasms 3 NSCLC 3 Meningioma 3 Gastrointestinal Neoplasms 3 Unresectable Locally Recurrent Rectal Cancer 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Spinal Cord Compression 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Epidural Neoplasms 2 Carcinoma, Transitional Cell 2 Adenocarcinoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1

Interventions

Cyclophosphamide 9 X-Rays 8 Specimen Handling 8 Phantoms, Imaging 7 fludarabine 6 Magnetic Resonance Spectroscopy 6 cabozantinib 5 Gemcitabine 5 Biopsy 5 Nuclear Medicine Department, Hospital 4 Methotrexate 4 Doxorubicin 4 fludarabine phosphate 3 Ifosfamide 3 Cisplatin 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 pembrolizumab 2 palbociclib 2 olaparib 2 mifamurtide 2 larotrectinib 2 ivosidenib 2 irinotecan sucrosofate 2 ensartinib 2 atezolizumab 2 Vincristine 2 Temozolomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Radiosurgery × 90 days × Clear all

NCT06492954 2026-06-02

AflacST2301

Emory University

Phase 1 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡